Xcout IntelSign inSubscribe

Bioventus Inc.

BVSHealthcareDurham, United States

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company’s restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.

Subscribe to see Bioventus Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Bioventus Inc. at a glance

Bioventus Inc. is a healthcare company headquartered in Durham, United States. It is publicly listed (BVS) with a market capitalisation of $940.3M. Xcout tracks 27 named people at Bioventus Inc., including Robert Claypoole (President, Chief Executive Officer & Director).

Industry
Healthcare
Headquarters
Durham, United States
Market cap
$940.3M
Employees
940
Ticker
BVS

Bioventus Inc. leadership

  • Robert ClaypoolePresident, Chief Executive Officer & Director
  • Mark SingletonSenior Vice President & Chief Financial Officer
  • Helen LeupoldSenior Vice President & Chief Human Resources Officer
  • Katrina ChurchChief Compliance Officer
  • Katrina J. ChurchSenior Vice President & Chief Compliance Officer
  • Mark SingletonSenior Vice President and Chief Financial Officer

21 more named people on record for Bioventus Inc., with roles, board committees and tenure — see the full roster →

Bioventus Inc. competitors

A few of Bioventus Inc.'s closest competitors — see the full list of competitors and alternatives →

Get Bioventus Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Bioventus Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Bioventus Inc. in Xcout Intel

  • 27 named people with titles, LinkedIn and board committees
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →